High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes (review).
about
The Role of AGE/RAGE Signaling in Diabetes-Mediated Vascular CalcificationMolecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targetsPeroxide-inducible Ets-1 mediates platelet-derived growth factor receptor-alpha gene transcription in vascular smooth muscle cellsAngiotensin II receptors and drug discovery in cardiovascular disease.Hypoxia stimulates the proliferation of neonatal rat vascular smooth muscle cells through activation of hypoxia-inducible factor-1αDecoding the oxidative stress hypothesis in diabetic embryopathy through proapoptotic kinase signaling.Advances in revealing the molecular targets downstream of oxidative stress-induced proapoptotic kinase signaling in diabetic embryopathy.Hyperglycemia, diabetes and stroke: focus on the cerebrovasculature.Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.Impaired coronary and retinal vasomotor function to hyperoxia in Individuals with Type 2 diabetes.Docosahexaenoic Acid Inhibits Vascular Smooth Muscle Cell Proliferation Induced by Glucose Variability.cAMP activates the generation of reactive oxygen species and inhibits the secretion of IL-6 in peripheral blood mononuclear cells from type 2 diabetic patients.Protein kinase C upregulates intercellular adhesion molecule-1 and leukocyte-endothelium interactions in hyperglycemia via activation of endothelial expressed calpainGlycosylated human oxyhaemoglobin activates nuclear factor-kappaB and activator protein-1 in cultured human aortic smooth muscle.Diabetes and risk of Kaposi's sarcoma: effects of high glucose on reactivation and infection of Kaposi's sarcoma-associated herpesvirus.Novel diacylglycerol kinase inhibitor selectively suppressed an U46619-induced enhancement of mouse portal vein contraction under high glucose conditions.
P2860
Q26740003-3D67FD18-A7C9-4A73-8B8D-1740ED23BD38Q27014620-50E1182C-7EF5-4744-8DA1-13ECECE3CB5BQ28571261-A409DFCC-C186-4FBC-A056-C46C5D097ADFQ34496676-DCB932C5-356C-4BC5-8E37-55A621A9A192Q35173501-20143627-A529-4D6E-8F8B-3016F15DD860Q35561699-BC0569CD-FD0B-496F-85CD-DE629B1E137FQ35847202-97823070-75B9-4864-84B1-7483104CA753Q37067129-B403E17A-344B-4AA8-AB8B-6152928BE43FQ37254899-E4F60CFB-1975-4312-938F-2F5F66F61A3FQ37334645-3B759C87-0A2D-4D69-803D-CA6F939AEC0DQ38609268-B40B0330-CA12-4697-9838-251CEE754B3AQ39534564-E426D41B-9CE6-4007-9E3B-7E85236338E7Q41766019-81C3483A-8662-410B-9000-4F37ECD1D1F4Q41827463-9C70F376-FE90-4306-9897-69387474CB4FQ43140967-2A6A1BE6-3556-4890-952B-36CF2A5DC917Q43262205-DBDA5BE4-E972-4827-A74C-118D29F069A1
P2860
High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes (review).
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
High glucose-induced activatio ...... function in diabetes (review).
@ast
High glucose-induced activatio ...... function in diabetes (review).
@en
High glucose-induced activatio ...... scular dysfunction in diabetes
@nl
type
label
High glucose-induced activatio ...... function in diabetes (review).
@ast
High glucose-induced activatio ...... function in diabetes (review).
@en
High glucose-induced activatio ...... scular dysfunction in diabetes
@nl
prefLabel
High glucose-induced activatio ...... function in diabetes (review).
@ast
High glucose-induced activatio ...... function in diabetes (review).
@en
High glucose-induced activatio ...... scular dysfunction in diabetes
@nl
P1476
High glucose-induced activatio ...... sfunction in diabetes (review)
@en
P2093
Ashok K Srivastava
P577
2002-01-01T00:00:00Z